Burdenko Central Military Clinical Hospital

Moscow 105299

0 studies enrolling now · 2 studies all time

What they study most

Disease, Hodgkin, Myelodysplastic Syndromes

Studies at this site

• A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) — Completed
• A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care — Completed